Rapid loss of efficacy of biosimilar infliximab in three patients with Behçet’s disease after switching from infliximab originator

Three patients affected by Behçet’s disease (BD) with severe uveitis and neurological involvement in stable clinical remission and who rapidly relapsed after switching from reference infliximab (re-IFX) to biosimilar infliximab (bio-IFX) are reported. In order to observe the rules of local health au...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Rheumatol
Autors principals: Cantini, Fabrizio, Niccoli, Laura, Nannini, Carlotta, Cassarà, Emanuele, Kaloudi, Olga
Format: Artigo
Idioma:Inglês
Publicat: Medical Research and Education Association 2017
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5741345/
https://ncbi.nlm.nih.gov/pubmed/29308287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2017.16112
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars